New Releases from NCBI BookshelfPembrolizumab (Keytruda): Therapeutic area: Advanced or metastatic malignant pleural mesothelioma (MPM): Reimbursement Review [Internet].Pembrolizumab (Keytruda): Therapeutic area: Advanced or metastatic malignant pleural mesothelioma (MPM): Reimbursement Review [Internet].
Post Content
